Lung Cancers Withdrawn Phase 1 Trials for Vandetanib (DB05294)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Withdrawn1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00937417S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid TumorsTreatment